Global Geographic Atrophy Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The Global Geographic Atrophy Report published by the Extent Research includes all the market segment analysis along with growth factors, threats, opportunities, and limitations. All these points are well discussed within the Geographic Atrophy report. The report provides guidance and assistance to the market players and the new entrants to make appropriate decisions in this time of COVID-19. During this time too the market players can make profits and can also improve their funding which is properly explained in detail in the Geographic Atrophy report. With the help of proper market research tools and research methodologies, research analysts have en routed proper and precise information about the Geographic Atrophy market in the report. The influencing factors and the market strategies that are augmenting the growth of the Geographic Atrophy market are enlisted in this comprehensive report.

Data provided by Extent Research. Source: https://www.extentresearch.com/geographic-atrophy-market

The research analysts have anticipated that the Geographic Atrophy market valuation for the forecast period will be significant. Furthermore, the Geographic Atrophy market is segmented based on by Application Late-stage (Phase III), Phase II, Phase I, Pre-clinical stage, , by Product type Above 60 Years, Above 75 Years, . Regional analysis has been conducted on major five regions, which includes North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. The major key market players that are incorporated in the Geographic Atrophy market report are Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies, Roche, Gensight Biologics, NGM Biopharmaceuticals, AstraZeneca, Lineage Cell Therapeutics, Allergan, .

The report provides data about all the historical, current, and future market prospects. The data within the report is represented in a unique and holistic pattern such that the global Geographic Atrophy market analysis is well understood.

Highlights of the Geographic Atrophy Market Report

Detailed study on the Geographic Atrophy market dynamics and segment analysis
Complete market scenario of the Geographic Atrophy market on the global platform
360 degree review about market adaptations and developments
Realistic and flexible changes that has affected market statistics and growth
Market strategies that have worked well by the key players
Market size and volume valuations and the foreseeable growth projections

Report Scope and Market Segmentation

ATTRIBUTES	Global Geographic Atrophy Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Geographic Atrophy Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Geographic Atrophy Market Size Growth Rate by Type: 2017 VS 2021 VS 2035
        1.2.2 Above 60 Years
        1.2.3 Above 75 Years
    1.3 Market by Application
        1.3.1 Global Geographic Atrophy Market Share by Application: 2017 VS 2021 VS 2035
        1.3.2 Late-stage (Phase III)
        1.3.3 Phase II
        1.3.4 Phase I
        1.3.5 Pre-clinical stage
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Geographic Atrophy Market Perspective (2017-2035)
    2.2 Geographic Atrophy Growth Trends by Region
        2.2.1 Geographic Atrophy Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Geographic Atrophy Historic Market Size by Region (2017-2022)
        2.2.3 Geographic Atrophy Forecasted Market Size by Region (2023-2035)
    2.3 Geographic Atrophy Market Dynamics
        2.3.1 Geographic Atrophy Industry Trends
        2.3.2 Geographic Atrophy Market Drivers
        2.3.3 Geographic Atrophy Market Challenges
        2.3.4 Geographic Atrophy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Geographic Atrophy Players by Revenue
        3.1.1 Global Top Geographic Atrophy Players by Revenue (2017-2022)
        3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2017-2022)
    3.2 Global Geographic Atrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Geographic Atrophy Revenue
    3.4 Global Geographic Atrophy Market Concentration Ratio
        3.4.1 Global Geographic Atrophy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Revenue in 2021
    3.5 Geographic Atrophy Key Players Head office and Area Served
    3.6 Key Players Geographic Atrophy Product Solution and Service
    3.7 Date of Enter into Geographic Atrophy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Breakdown Data by Type
    4.1 Global Geographic Atrophy Historic Market Size by Type (2017-2022)
    4.2 Global Geographic Atrophy Forecasted Market Size by Type (2023-2035)
5 Geographic Atrophy Breakdown Data by Application
    5.1 Global Geographic Atrophy Historic Market Size by Application (2017-2022)
    5.2 Global Geographic Atrophy Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Geographic Atrophy Market Size (2017-2035)
    6.2 North America Geographic Atrophy Market Size by Country (2017-2022)
    6.3 North America Geographic Atrophy Market Size by Country (2023-2035)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Geographic Atrophy Market Size (2017-2035)
    7.2 Europe Geographic Atrophy Market Size by Country (2017-2022)
    7.3 Europe Geographic Atrophy Market Size by Country (2023-2035)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Geographic Atrophy Market Size (2017-2035)
    8.2 Asia-Pacific Geographic Atrophy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Geographic Atrophy Market Size by Country (2023-2035)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Geographic Atrophy Market Size (2017-2035)
    9.2 Latin America Geographic Atrophy Market Size by Country (2017-2022)
    9.3 Latin America Geographic Atrophy Market Size by Country (2023-2035)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Geographic Atrophy Market Size (2017-2035)
    10.2 Middle East & Africa Geographic Atrophy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Geographic Atrophy Market Size by Country (2023-2035)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Apellis Pharmaceuticals
        11.1.1 Apellis Pharmaceuticals Company Detail
        11.1.2 Apellis Pharmaceuticals Business Overview
        11.1.3 Apellis Pharmaceuticals Geographic Atrophy Introduction
        11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2017-2022)
        11.1.5 Apellis Pharmaceuticals Recent Development
    11.2 Iveric Bio
        11.2.1 Iveric Bio Company Detail
        11.2.2 Iveric Bio Business Overview
        11.2.3 Iveric Bio Geographic Atrophy Introduction
        11.2.4 Iveric Bio Revenue in Geographic Atrophy Business (2017-2022)
        11.2.5 Iveric Bio Recent Development
    11.3 Alkeus Pharmaceuticals
        11.3.1 Alkeus Pharmaceuticals Company Detail
        11.3.2 Alkeus Pharmaceuticals Business Overview
        11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Introduction
        11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2017-2022)
        11.3.5 Alkeus Pharmaceuticals Recent Development
    11.4 Hemera Biosciences
        11.4.1 Hemera Biosciences Company Detail
        11.4.2 Hemera Biosciences Business Overview
        11.4.3 Hemera Biosciences Geographic Atrophy Introduction
        11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Business (2017-2022)
        11.4.5 Hemera Biosciences Recent Development
    11.5 Allegro Ophthalmics
        11.5.1 Allegro Ophthalmics Company Detail
        11.5.2 Allegro Ophthalmics Business Overview
        11.5.3 Allegro Ophthalmics Geographic Atrophy Introduction
        11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Business (2017-2022)
        11.5.5 Allegro Ophthalmics Recent Development
    11.6 Stealth BioTherapeutics
        11.6.1 Stealth BioTherapeutics Company Detail
        11.6.2 Stealth BioTherapeutics Business Overview
        11.6.3 Stealth BioTherapeutics Geographic Atrophy Introduction
        11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2017-2022)
        11.6.5 Stealth BioTherapeutics Recent Development
    11.7 Gyroscope Therapeutics
        11.7.1 Gyroscope Therapeutics Company Detail
        11.7.2 Gyroscope Therapeutics Business Overview
        11.7.3 Gyroscope Therapeutics Geographic Atrophy Introduction
        11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2017-2022)
        11.7.5 Gyroscope Therapeutics Recent Development
    11.8 Regenerative Patch Technologies
        11.8.1 Regenerative Patch Technologies Company Detail
        11.8.2 Regenerative Patch Technologies Business Overview
        11.8.3 Regenerative Patch Technologies Geographic Atrophy Introduction
        11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2017-2022)
        11.8.5 Regenerative Patch Technologies Recent Development
    11.9 Roche
        11.9.1 Roche Company Detail
        11.9.2 Roche Business Overview
        11.9.3 Roche Geographic Atrophy Introduction
        11.9.4 Roche Revenue in Geographic Atrophy Business (2017-2022)
        11.9.5 Roche Recent Development
    11.10 Gensight Biologics
        11.10.1 Gensight Biologics Company Detail
        11.10.2 Gensight Biologics Business Overview
        11.10.3 Gensight Biologics Geographic Atrophy Introduction
        11.10.4 Gensight Biologics Revenue in Geographic Atrophy Business (2017-2022)
        11.10.5 Gensight Biologics Recent Development
    11.11 NGM Biopharmaceuticals
        11.11.1 NGM Biopharmaceuticals Company Detail
        11.11.2 NGM Biopharmaceuticals Business Overview
        11.11.3 NGM Biopharmaceuticals Geographic Atrophy Introduction
        11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2017-2022)
        11.11.5 NGM Biopharmaceuticals Recent Development
    11.12 AstraZeneca
        11.12.1 AstraZeneca Company Detail
        11.12.2 AstraZeneca Business Overview
        11.12.3 AstraZeneca Geographic Atrophy Introduction
        11.12.4 AstraZeneca Revenue in Geographic Atrophy Business (2017-2022)
        11.12.5 AstraZeneca Recent Development
    11.13 Lineage Cell Therapeutics
        11.13.1 Lineage Cell Therapeutics Company Detail
        11.13.2 Lineage Cell Therapeutics Business Overview
        11.13.3 Lineage Cell Therapeutics Geographic Atrophy Introduction
        11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2017-2022)
        11.13.5 Lineage Cell Therapeutics Recent Development
    11.14 Allergan
        11.14.1 Allergan Company Detail
        11.14.2 Allergan Business Overview
        11.14.3 Allergan Geographic Atrophy Introduction
        11.14.4 Allergan Revenue in Geographic Atrophy Business (2017-2022)
        11.14.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Geographic Atrophy Market